Phillip Mertz

Director/Board Member at ALPHA COGNITION INC.

Net worth: 728 377 $ as of 2024-03-30

Health Technology

Consumer Services

Profile

Phillip P.
Mertz is the founder of Secure Open Solutions.
He is currently the Chief Executive Officer at Subtle Technologies and the Director at Alpha Cognition, Inc. He previously worked as a Director at Alpha Cognition, Inc. Mr. Mertz received his undergraduate degree from Harvard University in 2006.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALPHA COGNITION INC 1.43%	2023-08-28	1,255,822 ( 1.43% )	728 377 $	2024-03-30

Phillip Mertz active positions

Companies	Position	Start
ALPHA COGNITION INC.	Director/Board Member	2021-03-21

All active positions of Phillip Mertz

Former positions of Phillip Mertz

Companies	Position	End
Alpha Cognition, Inc. /old/ Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada.	Director/Board Member	-

See the detail of Phillip Mertz's experience

Training of Phillip Mertz

Harvard University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Phillip Mertz's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ALPHA COGNITION INC.	Health Technology

Private companies	1
Alpha Cognition, Inc. /old/ Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada.	Health Technology